European Economic
and Social Committee
Customs reform package
Key points
The EESC:
- highlights the need to attract specialised expertise for customs in non-traditional domains such as environmental protection, communication, customer support and social security, by promoting customs careers among the younger generation and implementating training and re-skilling programmes across all Member States;
- advocates for a clearly defined strategy to integrate AI into customs systems, while preserving ethical considerations at every stage of the process;
- disagrees with the proposal to treat an application as denied if any customs authority misses the set deadlines for communicating its decision. Contrary to the Commission proposal, applications should be considered accepted in such cases;
- recommends that EU companies should be granted unrestricted access to all laws, regulations, guidelines, and pertinent advice concerning their customs-related operations. The EESC specifically asks for a dedicated role for the EU Customs Authority (EUCA) in supporting SMEs.
For more information please contact the INT Section Secretariat
Downloads
Recommended for you
Customs reform package
News
Background The EU customs system needs to be overhauled to adjust to the new realities we are facing today, in particular modern supply chains and the expansion of e-commerce. Still very fragmented,…
The EU Banking Reform Package
Event
A proposed review of EU banking rules aims at ensuring that EU banks become more resilient to potential future economic shocks, while contributing to Europe's recovery from the COVID-19 pandemic and…
The EU Banking reform package - Minutes
Document
Single Market and Customs Programme 2028-2034
Opinion
EESC opinion on the Proposal for a Regulation of the European Parliament and of the Council establishing the Single Market and Customs Programme for the period 2028-2034 and repealing Regulations (EU…
Pharmaceutical package
Opinion
Key pointsThe EESC:supports the aim to improve the availability and accessibility of affordable medicines and boost the competitiveness as well as attractiveness of the EU pharmaceutical industry…